Overview

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
Non-inferiority trial to determine whether partial oral treatment is non-inferior to OPAT(Outpatient parenteral therapy) in patients diagnosed with infective endocarditis
Phase:
Phase 4
Details
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Treatments:
Amoxicillin
Cefaclor
Ciprofloxacin
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Dicloxacillin
Fusidic Acid
Levofloxacin
Linezolid
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ofloxacin
Oxazolidinones
Rifampin
Sulfamethoxazole
Tedizolid
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination